Charles B. O'Keeffe, Director at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 25,000 shares at $0.42 ($11K) on 2012-11-15, disclosed to the SEC on 2012-11-15.
Seasonal purchase ($10k) by Director — this insider has traded CPRX in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CPRX | BUY | 2019-10-11 | $47K | — | Filing → |
| CPRX | BUY | 2018-12-14 | $50K | — | Filing → |
| CPRX | BUY | 2018-06-08 | $3K | — | Filing → |